missing translation for 'onlineSavingsMsg'
Learn More
Learn More
Invitrogen™ CFHR1 Polyclonal Antibody

Rabbit Polyclonal Antibody
Brand: Invitrogen™ PA558592
This item is not returnable.
View return policy
Description
Immunogen sequence: TGESAEFVCK RGYRLSSRSH TLRTTCWDGK LEYPTCA Highest antigen sequence identity to the following orthologs: Mouse - 49%, Rat - 49%.
This gene encodes a secreted protein belonging to the complement factor H protein family. It binds to Pseudomonas aeruginosa elongation factor Tuf together with plasminogen, which is proteolytically activated. It is proposed that Tuf acts as a virulence factor by acquiring host proteins to the pathogen surface, controlling complement, and facilitating tissue invasion. Mutations in this gene are associated with an increased risk of atypical hemolytic-uremic syndrome.
Specifications
| CFHR1 | |
| Polyclonal | |
| Unconjugated | |
| CFHR1 | |
| AI194696; CFHL; Cfhl1; CFHL1P; CFHR1; CFHR1P; CFHRB; complement component factor h-like 1; complement factor H related 1; complement factor H-related 1; complement factor H-related 1 pseudogene; complement factor H-related protein; complement factor H-related protein 1; FHR1; FHR-1; H factor (complement)-like 1; H factor (complement)-like 2; h factor-like protein 1; H36; H36-1; H36-2; H-factor-like 1; HFL1; HFL2 | |
| Rabbit | |
| Antigen affinity chromatography | |
| RUO | |
| 3078 | |
| Store at 4°C short term. For long term storage, store at -20°C, avoiding freeze/thaw cycles. | |
| Liquid |
| Immunohistochemistry (Paraffin), Western Blot, Immunocytochemistry | |
| 0.05 mg/mL | |
| PBS with 40% glycerol and 0.02% sodium azide; pH 7.2 | |
| Q03591 | |
| CFHR1 | |
| Recombinant protein corresponding to Human CFHR1. Recombinant protein control fragment (Product #RP-98815). | |
| 100 μL | |
| Primary | |
| Human | |
| Antibody | |
| IgG |
Product Content Correction
Your input is important to us. Please complete this form to provide feedback related to the content on this product.
Product Title
Spot an opportunity for improvement?Share a Content Correction